NCT04135833
- Conditions
- NSCLC
- Locations
-
- Shanghai Xuhui Central Hospital Shanghai, China
Clinical trial condition
NSCLC
Explore clinical trials studying NSCLC. Study availability and eligibility vary by location and protocol.
367 public trials
125 recruiting studies
NSCLC trial results
NCT04032821
- Conditions
- NSCLC
- Locations
-
- The first Bethune hospital of jilin university Changchun, Jilin, China
NCT04670107
- Conditions
- Angiogenesis, Immunotherapy, NSCLC
- Locations
-
- The Affiliated Hospital of Qingdao University Qingdao, China
Completed
Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLC
NCT02954172
- Conditions
- NSCLC
- Locations
-
- Cancer Center; Sun Yat sen University; Guangzhou, Guangdong, China
NCT03301688
- Conditions
- NSCLC
- Locations
-
- Cancer Hospital Chinese Academy of Medical Science Beijing, Beijing Municipality, China
NCT00866970
- Conditions
- Body Weight, Body Weight Changes, Cachexia, +13 more
- Locations
-
- Rivercity Hospital Research Centre Auchenflower, Queensland, Australia
- Australian Clinical Research Organisation Kippa-Ring, Queensland, Australia
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Palliative Care Launceston General Hospital Launceston, Tasmania, Australia
Completed
A Phase I Study to Determine the Effect of Food on the Pharmacokinetic Profile of BPI-7711
NCT04135820
- Conditions
- NSCLC
- Locations
-
- Shanghai Ninth People's Hospital Shanghai, China
NCT02382796
- Conditions
- NSCLC
- Locations
-
- Kanazawa University Hospital Kanazawa, Ishikawa-ken, Japan
- Kurashiki Central Hospital Kurashiki, Okayama-ken, Japan
- Osaka City General Hospital Department of Clinical Oncology Osaka, Japan
- Kindai University Hospital Sayama, Osaka, Japan
Completed
ATOM_local Ablative Therapy
NCT01941654
- Conditions
- Activating EGFR Mutation, NSCLC
- Locations
-
- Department of Clinical Oncology Hong Kong
Completed
Olaparib Dose Escalating Trial + Concurrent RT With or Without Cisplatin in Locally Advanced NSCLC
NCT01562210
- Conditions
- NSCLC
- Locations
-
- Netherlands Cancer Institute - Antoni van Leeuwenhoek Ziekenhuis (NKI-AVL) Amsterdam, North Holland, Netherlands